ATE222487T1 - Brausemittel und dessen herstellung - Google Patents
Brausemittel und dessen herstellungInfo
- Publication number
- ATE222487T1 ATE222487T1 AT96306486T AT96306486T ATE222487T1 AT E222487 T1 ATE222487 T1 AT E222487T1 AT 96306486 T AT96306486 T AT 96306486T AT 96306486 T AT96306486 T AT 96306486T AT E222487 T1 ATE222487 T1 AT E222487T1
- Authority
- AT
- Austria
- Prior art keywords
- active substance
- physiologically active
- effortable
- products
- production
- Prior art date
Links
- 239000013543 active substance Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 239000011258 core-shell material Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000002702 enteric coating Substances 0.000 abstract 1
- 238000009505 enteric coating Methods 0.000 abstract 1
- 230000037406 food intake Effects 0.000 abstract 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 abstract 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 abstract 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 230000035807 sensation Effects 0.000 abstract 1
- 239000007921 spray Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 229920003169 water-soluble polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25706495 | 1995-09-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE222487T1 true ATE222487T1 (de) | 2002-09-15 |
Family
ID=17301247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96306486T ATE222487T1 (de) | 1995-09-08 | 1996-09-06 | Brausemittel und dessen herstellung |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US5824339A (de) |
| EP (1) | EP0761212B1 (de) |
| AT (1) | ATE222487T1 (de) |
| CA (1) | CA2184964A1 (de) |
| DE (1) | DE69623087T2 (de) |
Families Citing this family (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE512835C2 (sv) * | 1996-01-08 | 2000-05-22 | Astrazeneca Ab | Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare |
| SE9600071D0 (sv) * | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients I |
| US6365185B1 (en) * | 1998-03-26 | 2002-04-02 | University Of Cincinnati | Self-destructing, controlled release peroral drug delivery system |
| WO1999053918A1 (en) | 1998-04-20 | 1999-10-28 | Eisai Co., Ltd. | Stabilized compositions containing benzimidazole-type compounds |
| DE69934505T2 (de) * | 1998-05-18 | 2007-10-04 | Takeda Pharmaceutical Co. Ltd. | Im munde zerfallende tablette enthaltend ein benzimidazole |
| TW585786B (en) * | 1998-07-28 | 2004-05-01 | Takeda Chemical Industries Ltd | Lansoprazole-containing rapidly disintegrable solid pharmaceutical composition |
| EP1169024B1 (de) * | 1999-03-31 | 2005-12-21 | Janssen Pharmaceutica N.V. | Vorgelatinierte stärke in einer formulierung mit gesteuerter freigabe |
| GB9909801D0 (en) * | 1999-04-28 | 1999-06-23 | Btg Int Ltd | Ultrasound detectable instrument |
| AU6087100A (en) * | 1999-07-12 | 2001-01-30 | Smithkline Beecham Corporation | Heartburn treatment |
| US6264984B1 (en) | 1999-12-06 | 2001-07-24 | Bristol-Myers Squibb Company | Effervescent histamine H2 antagonist composition |
| US6589555B2 (en) | 1999-12-29 | 2003-07-08 | Mahendra Pandya | Effervescent vitaceutical compositions and related methods |
| AU2001236055A1 (en) * | 2000-03-02 | 2001-09-12 | Basf Aktiengesellschaft | Coated granules and foaming compositions containing the same |
| WO2001091730A1 (en) | 2000-05-31 | 2001-12-06 | Drugtech Corporation | Mineral supplement |
| WO2002026210A2 (en) * | 2000-09-29 | 2002-04-04 | Geneva Pharmaceuticals Inc. | Proton pump inhibitor formulation |
| US6558709B2 (en) | 2001-01-05 | 2003-05-06 | Howmedica Osteonics Corp. | Calcium phosphate composition and method of preparing same |
| CA2445347C (en) * | 2001-04-24 | 2011-09-27 | Lintec Corporation | An orally administered agent and an orally administered agent/supporting substrate complex |
| JP4993652B2 (ja) * | 2004-03-31 | 2012-08-08 | リンテック株式会社 | 経口投与剤 |
| US8268333B2 (en) * | 2001-04-24 | 2012-09-18 | Lintec Corporation | Orally administered agent and an orally administered agent/supporting substrate complex |
| JP4019374B2 (ja) * | 2001-07-27 | 2007-12-12 | アステラス製薬株式会社 | 口腔内速崩壊錠用徐放性微粒子含有組成物およびその製造法 |
| US20040005362A1 (en) * | 2002-07-03 | 2004-01-08 | Rajneesh Taneja | Liquid dosage forms of acid labile drugs |
| US20040082618A1 (en) * | 2002-07-03 | 2004-04-29 | Rajneesh Taneja | Liquid dosage forms of acid labile drugs |
| RU2332237C2 (ru) * | 2002-08-02 | 2008-08-27 | Рациофарм Гмбх | Фармацевтический препарат, содержащий производное бензимидазола, смешанное с микрокристаллической целлюлозой, и способ его изготовления |
| US7048959B1 (en) | 2003-01-09 | 2006-05-23 | Kulisch Michael A | Kinetic beverage for delivery of physiologically active substances |
| US20050220870A1 (en) * | 2003-02-20 | 2005-10-06 | Bonnie Hepburn | Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
| US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| JP3881640B2 (ja) * | 2003-08-08 | 2007-02-14 | 塩野義製薬株式会社 | ロラタジンを含むドライシロップ剤 |
| WO2005076987A2 (en) * | 2004-02-10 | 2005-08-25 | Santarus, Inc. | Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent |
| JP2005298471A (ja) * | 2004-03-17 | 2005-10-27 | Lintec Corp | 薬剤の製造方法 |
| US7740883B2 (en) * | 2004-03-28 | 2010-06-22 | University Of Debrecen | Nanoparticles from chitosan |
| US8192758B2 (en) * | 2004-03-30 | 2012-06-05 | Relypsa, Inc. | Ion binding compositions |
| BRPI0509365B8 (pt) * | 2004-03-30 | 2021-05-25 | Ilypsa Inc | composição farmacêutica, kit farmacêutico, e, uso da referida composição |
| US8282960B2 (en) * | 2004-03-30 | 2012-10-09 | Relypsa, Inc. | Ion binding compositions |
| JP2005289867A (ja) * | 2004-03-31 | 2005-10-20 | Lintec Corp | 経口投与剤 |
| EP1742630A4 (de) * | 2004-04-16 | 2010-01-20 | Santarus Inc | Kombination aus protonenpumpenhemmer, puffermittel und prokinetischem wirkstoff |
| US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US8815916B2 (en) | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| KR100627692B1 (ko) | 2004-11-02 | 2006-09-25 | (주)유라팜 | Ａｃｅ 억제제 함유 제제의 제조방법 및 그 제제 |
| US7536962B2 (en) * | 2005-04-19 | 2009-05-26 | Kamterter Ii, L.L.C. | Systems for the control and use of fluids and particles |
| US7311050B2 (en) * | 2005-04-19 | 2007-12-25 | Kamterter Ii, L.L.C. | Systems for the control and use of fluids and particles |
| US8308075B2 (en) | 2005-04-19 | 2012-11-13 | Kamterter Products, Llc | Systems for the control and use of fluids and particles |
| BRPI0616603A2 (pt) * | 2005-09-30 | 2012-12-25 | Ilypsa Inc | mÉtodo para preparar um compàsito de nécleo-envoltàrio, e para a manufatura de um medicamento, composiÇço farmacÊutica, e, uso da mesma |
| WO2007041569A1 (en) | 2005-09-30 | 2007-04-12 | Ilypsa, Inc. | Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal |
| CA2654402A1 (en) * | 2006-06-01 | 2007-12-06 | Adel Penhasi | Multiple unit pharmaceutical formulation |
| CN101595133B (zh) * | 2006-10-27 | 2012-11-14 | 比利时胶囊公司 | 羟丙基甲基纤维素硬胶囊及制备方法 |
| CA2667682A1 (en) | 2006-10-27 | 2008-05-15 | The Curators Of The University Of Missouri | Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same |
| US20080194307A1 (en) * | 2007-02-13 | 2008-08-14 | Jeff Sanger | Sports-based game of chance |
| US20090053367A1 (en) * | 2007-05-23 | 2009-02-26 | Michael Kulisch | Kinetic Beverage for Delivery of Physiologically Active Substances |
| JP2011512416A (ja) | 2008-02-20 | 2011-04-21 | ザ・キュレイターズ・オブ・ザ・ユニバーシティー・オブ・ミズーリ | オメプラゾール及びランソプラゾールの組合せと緩衝剤を含んでなる組成物とそれを使用する方法 |
| PT2365988E (pt) * | 2008-08-22 | 2015-10-22 | Relypsa Inc | Polímeros de permuta iónica reticulados, composições e uso no tratamento da hipercalemia |
| EP2168439B1 (de) * | 2008-09-30 | 2011-09-21 | Hitschler International GmbH & Co. KG | Dragierte Brausetabletten |
| CN101455196B (zh) * | 2008-12-23 | 2012-09-05 | 中国人民解放军海军医学研究所 | 一种农药泡腾组合物及其制备方法 |
| IT1395143B1 (it) * | 2009-08-06 | 2012-09-05 | Sofar Spa | Composizioni granulari a rilascio controllato di mesalazina e processo per il loro ottenimento. |
| FR2949062B1 (fr) * | 2009-08-12 | 2011-09-02 | Debregeas Et Associes Pharma | Nouvelles formulations pharmaceutiques contre le mesusage des medicaments |
| FR2949061B1 (fr) | 2009-08-12 | 2013-04-19 | Debregeas Et Associes Pharma | Microgranules flottants |
| US8232238B2 (en) | 2010-06-03 | 2012-07-31 | The Clorox Company | Concentrated film delivery systems |
| DE102010053748B4 (de) * | 2010-12-08 | 2023-08-03 | Jörg Schierholz | Pharmazeutische Zusammensetzung zur Behandlung von Übergewicht |
| US20170042806A1 (en) | 2015-04-29 | 2017-02-16 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
| WO2017066134A1 (en) * | 2015-10-16 | 2017-04-20 | Merck Sharp & Dohme Corp. | Processes for preparing formulations for gastrointestinal-targeted therapies |
| US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3131123A (en) * | 1959-03-13 | 1964-04-28 | Lab Francais De Therapeutique | Enteric tablets and manufacture thereof |
| SE416649B (sv) * | 1974-05-16 | 1981-01-26 | Haessle Ab | Forfarande for framstellning av foreningar som paverkar magsyrasekretionen |
| SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
| CA1193870A (en) * | 1980-08-14 | 1985-09-24 | Peter N. Tomlinson | Abrasive product |
| US4472409A (en) * | 1981-11-05 | 1984-09-18 | Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung | 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects |
| JPS6150978A (ja) * | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
| CA1266235A (en) * | 1985-03-25 | 1990-02-27 | Wallace E. Becker | Tablet composition for drug combinations |
| CA1327010C (en) * | 1986-02-13 | 1994-02-15 | Tadashi Makino | Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production |
| CA1276017C (en) * | 1986-02-13 | 1990-11-06 | Takeda Chemical Industries, Ltd. | Sulfenamide derivatives and their production |
| GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
| GB2189699A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated acid-labile medicaments |
| FI90544C (fi) * | 1986-11-13 | 1994-02-25 | Eisai Co Ltd | Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi |
| EP0452862B1 (de) * | 1990-04-18 | 1995-07-19 | Asahi Kasei Kogyo Kabushiki Kaisha | Kugelförmige Keimkerne, kugelförmige Granulate sowie Verfahren zu deren Herstellung |
| US5312824A (en) * | 1990-10-17 | 1994-05-17 | Takeda Chemical Industries, Ltd. | Certain 2-[(4-difluoromethoxy-2-pyridyl)-methylthio or methylsulfinyl-5-benzimidazoles useful for treating peptic ulcers |
| JP2820829B2 (ja) * | 1991-03-07 | 1998-11-05 | 武田薬品工業株式会社 | 有核散剤およびその製造方法 |
| CA2112663C (en) * | 1991-07-01 | 2002-04-23 | Thomas Gergely | Effervescent systems using reaction doping agents |
| US5503846A (en) * | 1993-03-17 | 1996-04-02 | Cima Labs, Inc. | Base coated acid particles and effervescent formulation incorporating same |
| ATE181672T1 (de) * | 1993-04-28 | 1999-07-15 | Takeda Chemical Industries Ltd | Geschmacksmaskierte feste zubereitung und verfahren zur herstellung |
| TW280770B (de) * | 1993-10-15 | 1996-07-11 | Takeda Pharm Industry Co Ltd | |
| DE69419492T2 (de) * | 1994-03-01 | 2000-02-03 | Gerhard Gergely | Ein Brausesystem und einen Arzneiwirkstoff enthaltendes granuläres Produkt bzw. Tablette sowie Verfahren zu deren Herstellung |
| SE9500478D0 (sv) * | 1995-02-09 | 1995-02-09 | Astra Ab | New pharmaceutical formulation and process |
-
1996
- 1996-09-05 US US08/708,663 patent/US5824339A/en not_active Expired - Lifetime
- 1996-09-06 AT AT96306486T patent/ATE222487T1/de not_active IP Right Cessation
- 1996-09-06 EP EP96306486A patent/EP0761212B1/de not_active Expired - Lifetime
- 1996-09-06 CA CA002184964A patent/CA2184964A1/en not_active Abandoned
- 1996-09-06 DE DE69623087T patent/DE69623087T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0761212A3 (de) | 1997-11-12 |
| EP0761212A2 (de) | 1997-03-12 |
| EP0761212B1 (de) | 2002-08-21 |
| DE69623087T2 (de) | 2003-04-24 |
| DE69623087D1 (de) | 2002-09-26 |
| US5824339A (en) | 1998-10-20 |
| CA2184964A1 (en) | 1997-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE222487T1 (de) | Brausemittel und dessen herstellung | |
| GEP20022707B (en) | Biodegrading Macromers for the Controlled Release of Biologically Active Substances | |
| HUT50050A (en) | Pharmaceutical compositions with controlled release of active ingredient and process for producing such compositions | |
| MX9704910A (es) | Formula de liberacion controlada (albuterol). | |
| UA40634C2 (uk) | Мікрокапсула, яка містить суспензію твердої біологічно активної сполуки, і спосіб її одержання | |
| AU6770490A (en) | Solid pharmaceutical compositions containing cimetidine | |
| ES2126536A1 (es) | "preparado farmaceutico para administracion intranasal"y procedimiento para su produccion. | |
| CA2119253A1 (en) | Medication Vehicles Made of Solid Lipid Particles (Solid Lipid Nanospheres-SLN) | |
| ES2077023T3 (es) | Material de recubrimiento que controla la liberacion de un medicamento para formulaciones de actividad prolongada. | |
| AU2925295A (en) | A novel drug delivery system | |
| AU1534699A (en) | Osmotic dosage form comprising first and second coats | |
| NO953278L (no) | Fremgangsmåter for in vivo-levering av biologisk aktive stoffer og sammensetninger som er nyttige for dette | |
| IE883810L (en) | Sustained release pharmaceutical compositions | |
| FR2774288B1 (fr) | Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques | |
| DE69519685D1 (de) | Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe | |
| DE3869002D1 (de) | Salbutamoltabletten mit hydrophiler matrix und verfahren zu ihrer herstellung. | |
| ES2071889T3 (es) | Medicamento oral y agente de recubrimiento, que contiene un polisaccarido que se descompone en el colon. | |
| DK1169032T3 (da) | Ketoprofen-mikrogranuler, fremgangsmåde til fremstilling deraf og farmaceutiske præparater | |
| CA2000932A1 (en) | Oral pharmaceutical controlled release multiple unit dosage form | |
| ATE366119T1 (de) | Chitosanpulver enthaltende feste zubereitungen und verfahren zu deren herstellung | |
| PL317996A1 (en) | Carbamazepinic form of a drug with retarded release of biologically active substance | |
| AU4914893A (en) | Oral medicament form | |
| GB2323532B (en) | Process for the preparation of a stable fixed dose pharmaceutical composition of anti-infective agent(s) and micro organisms as active ingredients | |
| GEP20033012B (en) | Liquid Polymeric Compositions for Controlled Release of Bioactive Substances | |
| IL105685A (en) | Multi-layered, microencapsulated pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |